© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Barbara Ryan
Articles
After Blowout 2020, Biotech Worst Performing Sector YTD
What are the reasons behind the slump and what does the future hold?
How Does it Feel When You Literally Can Change the World?
Adding context to Pfizer’s orbit-busting, first-quarter earnings.
Biopharma has Wind at its Back—Are Storm Clouds on Horizon?
More capital gains and the potential strains for rest of 2021.
Biopharma’s Reputation Gets a Well-Earned Shot in the Arm
Amid vaccine heroics, its complex story may finally be resonating.